Advertisement
Screener

Lineage Cell Therapeutics, Inc. (LCTX) Shares Issued

2.8 / 5 stars · 68/120 Roast Me

Lineage Cell Therapeutics, Inc. Shares Issued

Lineage Cell Therapeutics, Inc. (LCTX) had Shares Issued of 252.91 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesIssued · last filed 2026-08-06

  • 2026-06-30: Common Stock, Shares, Issued 252.91M shares.
  • 2026-03-31: Common Stock, Shares, Issued 249.30M shares.
  • 2025-12-31: Common Stock, Shares, Issued 243.12M shares.
  • 2025-09-30: Common Stock, Shares, Issued 230.33M shares.
Period endCommon Stock, Shares, IssuedCommon Stock, Shares, Issued as first filed
2026-06-30252.91M shares
10-Q · filed 2026-08-06
2026-03-31249.30M shares
10-Q · filed 2026-05-12
2025-12-31243.12M shares
10-Q · filed 2026-08-06
2025-09-30230.33M shares
10-Q · filed 2025-11-06
2025-06-30228.36M shares
10-Q · filed 2025-08-12
2025-03-31228.36M shares
10-Q · filed 2025-05-13
2024-12-31220.42M shares
10-K · filed 2026-03-05
2024-09-30188.84M shares
10-Q · filed 2024-11-14
2024-06-30188.82M shares
10-Q · filed 2024-08-08
2024-03-31188.75M shares
10-Q · filed 2024-05-09
2023-12-31174.99M shares
10-K · filed 2025-03-10
2023-09-30174.99M shares
10-Q · filed 2023-11-09
2023-06-30174.44M shares
10-Q · filed 2023-08-10
2023-03-31170.17M shares
10-Q · filed 2023-05-11
2022-12-31170.09M shares
10-K · filed 2024-03-07
2022-09-30169.89M shares
10-Q · filed 2022-11-10
2022-06-30169.75M shares
10-Q · filed 2022-08-11
2022-03-31169.73M shares
10-Q · filed 2022-05-12
2021-12-31169.48M shares
10-K · filed 2023-03-09
2021-09-30168.47M shares
10-Q · filed 2021-11-10
2021-06-30167.04M shares
10-Q · filed 2021-08-12
2021-03-31162.07M shares
10-Q · filed 2021-05-13
2020-12-31153.10M shares
10-K · filed 2022-03-10
2020-09-30149.99M shares
10-Q · filed 2020-11-04
2020-06-30149.83M shares
10-Q · filed 2020-08-06
2020-03-31149.82M shares
10-Q · filed 2020-05-07
2019-12-31149.80M shares
10-K · filed 2021-03-11
149.80M shares
10-K · filed 2020-03-12
2019-09-30149.79M shares
10-Q · filed 2019-11-12
2019-06-30149.64M shares
10-Q · filed 2019-08-08
2019-03-31149.39M shares
10-Q · filed 2019-05-09
2018-12-31127.14M shares
10-K · filed 2020-03-12
2018-09-30126.88M shares
10-Q · filed 2018-11-08
2018-06-30126.87M shares
10-Q · filed 2018-08-02
2018-03-31126.87M shares
10-Q · filed 2018-05-10
2017-12-31126.87M shares
10-K · filed 2019-03-14
2017-09-30115.80M shares
10-Q · filed 2017-11-09
2017-06-30110.88M shares
10-Q · filed 2017-08-09
2017-03-31110.86M shares
10-Q · filed 2017-05-10
2016-12-31103.40M shares
10-K · filed 2018-03-15
103.40M shares
10-K · filed 2017-03-16
2016-09-30103.39M shares
10-Q · filed 2016-11-04
2016-06-30102.29M shares
10-Q · filed 2016-08-09
2016-03-3194.89M shares
10-Q · filed 2016-05-10
2015-12-3194.89M shares
10-K · filed 2017-03-16
2015-09-3086.76M shares
10-Q · filed 2015-11-09
2015-06-3083.28M shares
10-Q · filed 2015-08-10
2015-03-3183.21M shares
10-Q · filed 2015-05-08
2014-12-3183.12M shares
10-K · filed 2016-03-15
2014-09-3073.69M shares
10-Q · filed 2014-11-07
2014-06-3072.27M shares
10-Q · filed 2014-08-11
2014-03-3169.62M shares
10-Q · filed 2014-05-12
2013-12-3167.41M shares
10-K · filed 2015-03-11
2013-09-3057.94M shares
10-Q · filed 2013-11-12
2013-06-3057.93M shares
10-Q · filed 2013-08-09
2013-03-3154.91M shares
10-Q · filed 2013-05-10
2012-12-3151.18M shares
10-K · filed 2014-03-17
2012-09-3050.87M shares
10-Q · filed 2012-11-09
2012-06-3050.79M shares
10-Q · filed 2012-08-09
2012-03-3150.32M shares
10-Q · filed 2012-05-10
2011-12-3150.32M shares
10-K · filed 2013-03-18
2011-09-3050.24M shares
10-Q · filed 2011-11-08
2011-06-3048.87M shares
10-Q · filed 2011-08-09
2010-12-3147.78M shares
10-K · filed 2012-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Alector, Inc. (ALEC)United States$0.213B-1.90
Invivyd, Inc. (IVVD)United States$0.270B-2.42
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51